Global Flu (Influenza) Vaccine Sales Market Report 2023

Report ID: 865136 | Published Date: Jan 2025 | No. of Page: 145 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Flu (Influenza) Vaccine Market Overview
    1.1 Flu (Influenza) Vaccine Product Scope
    1.2 Flu (Influenza) Vaccine Segment by Type
        1.2.1 Global Flu (Influenza) Vaccine Sales by Type (2016 & 2021 & 2027)
        1.2.2 Split Influenza Vaccine
        1.2.3 Pandemic Influenza Vaccine
        1.2.4 Subunit Influenza Vaccine
        1.2.5 Quadrivalent Influenza Vaccine
    1.3 Flu (Influenza) Vaccine Segment by Application
        1.3.1 Global Flu (Influenza) Vaccine Sales Comparison by Application (2016 & 2021 & 2027)
        1.3.2 For Children (6 months to 3 years)
        1.3.3 For Adults and Children over 3 years
    1.4 Flu (Influenza) Vaccine Market Estimates and Forecasts (2016-2027)
        1.4.1 Global Flu (Influenza) Vaccine Market Size in Value Growth Rate (2016-2027)
        1.4.2 Global Flu (Influenza) Vaccine Market Size in Volume Growth Rate (2016-2027)
        1.4.3 Global Flu (Influenza) Vaccine Price Trends (2016-2027)

2 Flu (Influenza) Vaccine Estimates and Forecasts by Region
    2.1 Global Flu (Influenza) Vaccine Market Size by Region: 2016 VS 2021 VS 2027
    2.2 Global Flu (Influenza) Vaccine Retrospective Market Scenario by Region (2016-2021)
        2.2.1 Global Flu (Influenza) Vaccine Sales Market Share by Region (2016-2021)
        2.2.2 Global Flu (Influenza) Vaccine Revenue Market Share by Region (2016-2021)
    2.3 Global Flu (Influenza) Vaccine Market Estimates and Forecasts by Region (2022-2027)
        2.3.1 Global Flu (Influenza) Vaccine Sales Estimates and Forecasts by Region (2022-2027)
        2.3.2 Global Flu (Influenza) Vaccine Revenue Forecast by Region (2022-2027)
    2.4 Geographic Market Analysis: Market Facts & Figures
        2.4.1 North America Flu (Influenza) Vaccine Estimates and Projections (2016-2027)
        2.4.2 Europe Flu (Influenza) Vaccine Estimates and Projections (2016-2027)
        2.4.3 China Flu (Influenza) Vaccine Estimates and Projections (2016-2027)
        2.4.4 Japan Flu (Influenza) Vaccine Estimates and Projections (2016-2027)
        2.4.5 Southeast Asia Flu (Influenza) Vaccine Estimates and Projections (2016-2027)
        2.4.6 India Flu (Influenza) Vaccine Estimates and Projections (2016-2027)
3 Global Flu (Influenza) Vaccine Competition Landscape by Players
    3.1 Global Top Flu (Influenza) Vaccine Players by Sales (2016-2021)
    3.2 Global Top Flu (Influenza) Vaccine Players by Revenue (2016-2021)
    3.3 Global Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu (Influenza) Vaccine as of 2020)
    3.4 Global Flu (Influenza) Vaccine Average Price by Company (2016-2021)
    3.5 Manufacturers Flu (Influenza) Vaccine Manufacturing Sites, Area Served, Product Type
    3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Flu (Influenza) Vaccine Market Size by Type
    4.1 Global Flu (Influenza) Vaccine Historic Market Review by Type (2016-2021)
        4.1.1 Global Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
        4.1.2 Global Flu (Influenza) Vaccine Revenue Market Share by Type (2016-2021)
        4.1.3 Global Flu (Influenza) Vaccine Price by Type (2016-2021)
    4.2 Global Flu (Influenza) Vaccine Market Estimates and Forecasts by Type (2022-2027)
        4.2.1 Global Flu (Influenza) Vaccine Sales Forecast by Type (2022-2027)
        4.2.2 Global Flu (Influenza) Vaccine Revenue Forecast by Type (2022-2027)
        4.2.3 Global Flu (Influenza) Vaccine Price Forecast by Type (2022-2027)
5 Global Flu (Influenza) Vaccine Market Size by Application
    5.1 Global Flu (Influenza) Vaccine Historic Market Review by Application (2016-2021)
        5.1.1 Global Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
        5.1.2 Global Flu (Influenza) Vaccine Revenue Market Share by Application (2016-2021)
        5.1.3 Global Flu (Influenza) Vaccine Price by Application (2016-2021)
    5.2 Global Flu (Influenza) Vaccine Market Estimates and Forecasts by Application (2022-2027)
        5.2.1 Global Flu (Influenza) Vaccine Sales Forecast by Application (2022-2027)
        5.2.2 Global Flu (Influenza) Vaccine Revenue Forecast by Application (2022-2027)
        5.2.3 Global Flu (Influenza) Vaccine Price Forecast by Application (2022-2027)

6 North America Flu (Influenza) Vaccine Market Facts & Figures
    6.1 North America Flu (Influenza) Vaccine Sales by Company
        6.1.1 North America Flu (Influenza) Vaccine Sales by Company (2016-2021)
        6.1.2 North America Flu (Influenza) Vaccine Revenue by Company (2016-2021)
    6.2 North America Flu (Influenza) Vaccine Sales Breakdown by Type
        6.2.1 North America Flu (Influenza) Vaccine Sales Breakdown by Type (2016-2021)
        6.2.2 North America Flu (Influenza) Vaccine Sales Breakdown by Type (2022-2027)
    6.3 North America Flu (Influenza) Vaccine Sales Breakdown by Application
        6.3.1 North America Flu (Influenza) Vaccine Sales Breakdown by Application (2016-2021)
        6.3.2 North America Flu (Influenza) Vaccine Sales Breakdown by Application (2022-2027)

7 Europe Flu (Influenza) Vaccine Market Facts & Figures
    7.1 Europe Flu (Influenza) Vaccine Sales by Company
        7.1.1 Europe Flu (Influenza) Vaccine Sales by Company (2016-2021)
        7.1.2 Europe Flu (Influenza) Vaccine Revenue by Company (2016-2021)
    7.2 Europe Flu (Influenza) Vaccine Sales Breakdown by Type
        7.2.1 Europe Flu (Influenza) Vaccine Sales Breakdown by Type (2016-2021)
        7.2.2 Europe Flu (Influenza) Vaccine Sales Breakdown by Type (2022-2027)
    7.3 Europe Flu (Influenza) Vaccine Sales Breakdown by Application
        7.3.1 Europe 145 Sales Breakdown by Application (2016-2021)
        7.3.2 Europe 145 Sales Breakdown by Application (2022-2027)

8 China Flu (Influenza) Vaccine Market Facts & Figures
    8.1 China Flu (Influenza) Vaccine Sales by Company
        8.1.1 China Flu (Influenza) Vaccine Sales by Company (2016-2021)
        8.1.2 China Flu (Influenza) Vaccine Revenue by Company (2016-2021)
    8.2 China Flu (Influenza) Vaccine Sales Breakdown by Type
        8.2.1 China Flu (Influenza) Vaccine Sales Breakdown by Type (2016-2021)
        8.2.2 China Flu (Influenza) Vaccine Sales Breakdown by Type (2022-2027)
    8.3 China Flu (Influenza) Vaccine Sales Breakdown by Application
        8.3.1 China 318 Sales Breakdown by Application (2016-2021)
        8.3.2 China 318 Sales Breakdown by Application (2022-2027)

9 Japan Flu (Influenza) Vaccine Market Facts & Figures
    9.1 Japan Flu (Influenza) Vaccine Sales by Company
        9.1.1 Japan Flu (Influenza) Vaccine Sales by Company (2016-2021)
        9.1.2 Japan Flu (Influenza) Vaccine Revenue by Company (2016-2021)
    9.2 Japan Flu (Influenza) Vaccine Sales Breakdown by Type
        9.2.1 Japan Flu (Influenza) Vaccine Sales Breakdown by Type (2016-2021)
        9.2.2 Japan Flu (Influenza) Vaccine Sales Breakdown by Type (2022-2027)
    9.3 Japan Flu (Influenza) Vaccine Sales Breakdown by Application
        9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
        9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Flu (Influenza) Vaccine Market Facts & Figures
    10.1 Southeast Asia Flu (Influenza) Vaccine Sales by Company
        10.1.1 Southeast Asia Flu (Influenza) Vaccine Sales by Company (2016-2021)
        10.1.2 Southeast Asia Flu (Influenza) Vaccine Revenue by Company (2016-2021)
    10.2 Southeast Asia Flu (Influenza) Vaccine Sales Breakdown by Type
        10.2.1 Southeast Asia Flu (Influenza) Vaccine Sales Breakdown by Type (2016-2021)
        10.2.2 Southeast Asia Flu (Influenza) Vaccine Sales Breakdown by Type (2022-2027)
    10.3 Southeast Asia Flu (Influenza) Vaccine Sales Breakdown by Application
        10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
        10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Flu (Influenza) Vaccine Market Facts & Figures
    11.1 India Flu (Influenza) Vaccine Sales by Company
        11.1.1 India Flu (Influenza) Vaccine Sales by Company (2016-2021)
        11.1.2 India Flu (Influenza) Vaccine Revenue by Company (2016-2021)
    11.2 India Flu (Influenza) Vaccine Sales Breakdown by Type
        11.2.1 India Flu (Influenza) Vaccine Sales Breakdown by Type (2016-2021)
        11.2.2 India Flu (Influenza) Vaccine Sales Breakdown by Type (2022-2027)
    11.3 India Flu (Influenza) Vaccine Sales Breakdown by Application
        11.3.1 India Flu (Influenza) Vaccine Sales Breakdown by Application (2016-2021)
        11.3.2 India Flu (Influenza) Vaccine Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Flu (Influenza) Vaccine Business
    12.1 Hualan Bio
        12.1.1 Hualan Bio Corporation Information
        12.1.2 Hualan Bio Business Overview
        12.1.3 Hualan Bio Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.1.4 Hualan Bio Flu (Influenza) Vaccine Products Offered
        12.1.5 Hualan Bio Recent Development
    12.2 CCBIO
        12.2.1 CCBIO Corporation Information
        12.2.2 CCBIO Business Overview
        12.2.3 CCBIO Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.2.4 CCBIO Flu (Influenza) Vaccine Products Offered
        12.2.5 CCBIO Recent Development
    12.3 Aleph Biomedical
        12.3.1 Aleph Biomedical Corporation Information
        12.3.2 Aleph Biomedical Business Overview
        12.3.3 Aleph Biomedical Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.3.4 Aleph Biomedical Flu (Influenza) Vaccine Products Offered
        12.3.5 Aleph Biomedical Recent Development
    12.4 SANOFI
        12.4.1 SANOFI Corporation Information
        12.4.2 SANOFI Business Overview
        12.4.3 SANOFI Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.4.4 SANOFI Flu (Influenza) Vaccine Products Offered
        12.4.5 SANOFI Recent Development
    12.5 Adimmune
        12.5.1 Adimmune Corporation Information
        12.5.2 Adimmune Business Overview
        12.5.3 Adimmune Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.5.4 Adimmune Flu (Influenza) Vaccine Products Offered
        12.5.5 Adimmune Recent Development
    12.6 ZYAK
        12.6.1 ZYAK Corporation Information
        12.6.2 ZYAK Business Overview
        12.6.3 ZYAK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.6.4 ZYAK Flu (Influenza) Vaccine Products Offered
        12.6.5 ZYAK Recent Development
    12.7 SINOVAC
        12.7.1 SINOVAC Corporation Information
        12.7.2 SINOVAC Business Overview
        12.7.3 SINOVAC Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.7.4 SINOVAC Flu (Influenza) Vaccine Products Offered
        12.7.5 SINOVAC Recent Development
    12.8 Changsheng Biological
        12.8.1 Changsheng Biological Corporation Information
        12.8.2 Changsheng Biological Business Overview
        12.8.3 Changsheng Biological Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.8.4 Changsheng Biological Flu (Influenza) Vaccine Products Offered
        12.8.5 Changsheng Biological Recent Development
    12.9 SIOBP
        12.9.1 SIOBP Corporation Information
        12.9.2 SIOBP Business Overview
        12.9.3 SIOBP Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.9.4 SIOBP Flu (Influenza) Vaccine Products Offered
        12.9.5 SIOBP Recent Development
    12.10 GSK
        12.10.1 GSK Corporation Information
        12.10.2 GSK Business Overview
        12.10.3 GSK Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.10.4 GSK Flu (Influenza) Vaccine Products Offered
        12.10.5 GSK Recent Development
    12.11 Aimei Hissen
        12.11.1 Aimei Hissen Corporation Information
        12.11.2 Aimei Hissen Business Overview
        12.11.3 Aimei Hissen Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.11.4 Aimei Hissen Flu (Influenza) Vaccine Products Offered
        12.11.5 Aimei Hissen Recent Development
    12.12 Tianyuan Bio-pharma(Novartis)
        12.12.1 Tianyuan Bio-pharma(Novartis) Corporation Information
        12.12.2 Tianyuan Bio-pharma(Novartis) Business Overview
        12.12.3 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.12.4 Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Products Offered
        12.12.5 Tianyuan Bio-pharma(Novartis) Recent Development
    12.13 Simcere Vaxtec
        12.13.1 Simcere Vaxtec Corporation Information
        12.13.2 Simcere Vaxtec Business Overview
        12.13.3 Simcere Vaxtec Flu (Influenza) Vaccine Sales, Revenue and Gross Margin (2016-2021)
        12.13.4 Simcere Vaxtec Flu (Influenza) Vaccine Products Offered
        12.13.5 Simcere Vaxtec Recent Development

13 Flu (Influenza) Vaccine Manufacturing Cost Analysis
    13.1 Flu (Influenza) Vaccine Key Raw Materials Analysis
        13.1.1 Key Raw Materials
        13.1.2 Key Raw Materials Price Trend
        13.1.3 Key Suppliers of Raw Materials
    13.2 Proportion of Manufacturing Cost Structure
    13.3 Manufacturing Process Analysis of Flu (Influenza) Vaccine
    13.4 Flu (Influenza) Vaccine Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
    14.1 Marketing Channel
    14.2 Flu (Influenza) Vaccine Distributors List
    14.3 Flu (Influenza) Vaccine Customers

15 Market Dynamics
    15.1 Flu (Influenza) Vaccine Market Trends
    15.2 Flu (Influenza) Vaccine Drivers
    15.3 Flu (Influenza) Vaccine Market Challenges
    15.4 Flu (Influenza) Vaccine Market Restraints

16 Research Findings and Conclusion

17 Appendix
    17.1 Research Methodology
        17.1.1 Methodology/Research Approach
        17.1.2 Data Source
    17.2 Author List
    17.3 Disclaimer
List of Tables
    Table 1. Global Flu (Influenza) Vaccine Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
    Table 2. Global Flu (Influenza) Vaccine Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
    Table 3. Global Flu (Influenza) Vaccine Market Size (US$ Million) by Region: 2016 VS 2021 &2027
    Table 4. Global Flu (Influenza) Vaccine Sales (K Units) by Region (2016-2021)
    Table 5. Global Flu (Influenza) Vaccine Sales Market Share by Region (2016-2021)
    Table 6. Global Flu (Influenza) Vaccine Revenue (US$ Million) Market Share by Region (2016-2021))
    Table 7. Global Flu (Influenza) Vaccine Revenue Share by Region (2016-2021)
    Table 8. Global Flu (Influenza) Vaccine Sales (K Units) Forecast by Region (2022-2027)
    Table 9. Global Flu (Influenza) Vaccine Sales Market Share Forecast by Region (2022-2027)
    Table 10. Global Flu (Influenza) Vaccine Revenue (US$ Million) Forecast by Region (2022-2027)
    Table 11. Global Flu (Influenza) Vaccine Revenue Share Forecast by Region (2022-2027)
    Table 12. Global Flu (Influenza) Vaccine Sales (K Units) of Key Companies (2016-2021)
    Table 13. Global Flu (Influenza) Vaccine Sales Share by Company (2016-2021)
    Table 14. Global Flu (Influenza) Vaccine Revenue (US$ Million) by Company (2016-2021)
    Table 15. Global Flu (Influenza) Vaccine Revenue Share by Company (2016-2021)
    Table 16. Global Flu (Influenza) Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Flu (Influenza) Vaccine as of 2020)
    Table 17. Global Flu (Influenza) Vaccine Average Price (US$/Unit) of Key Company (2016-2021)
    Table 18. Manufacturers Flu (Influenza) Vaccine Manufacturing Sites and Area Served
    Table 19. Manufacturers Flu (Influenza) Vaccine Product Type
    Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 21. Global Flu (Influenza) Vaccine Sales (K Units) by Type (2016-2021)
    Table 22. Global Flu (Influenza) Vaccine Sales Share by Type (2016-2021)
    Table 23. Global Flu (Influenza) Vaccine Revenue (US$ Million) Market Share by Type (2016-2021)
    Table 24. Global Flu (Influenza) Vaccine Price (US$/Unit) by Type (2016-2021)
    Table 25. Global Flu (Influenza) Vaccine Sales Share by Type (2022-2027)
    Table 26. Global Flu (Influenza) Vaccine Revenue (US$ Million) Market Share by Type (2022-2027) 
    Table 27. Global Flu (Influenza) Vaccine Revenue Share by Type (2022-2027)
    Table 28. Global Flu (Influenza) Vaccine Price (US$/Unit) by Type (2022-2027)
    Table 29. Global Flu (Influenza) Vaccine Sales (K Units) by Application (2016-2021) 
    Table 30. Global Flu (Influenza) Vaccine Sales Share by Application (2016-2021)
    Table 31. Global Flu (Influenza) Vaccine Revenue (US$ Million) Market Share by Application (2016-2021)
    Table 32. Global Flu (Influenza) Vaccine Price (US$/Unit) by Application (2016-2021)
    Table 33. Global Flu (Influenza) Vaccine Sales (K Units) by Application (2022-2027)
    Table 34. Global Flu (Influenza) Vaccine Sales Share by Application (2022-2027)
    Table 35. Global Flu (Influenza) Vaccine Revenue (US$ Million) Market Share by Application (2022-2027)
    Table 36. Global Flu (Influenza) Vaccine Revenue Share by Application (2022-2027)
    Table 37. Global Flu (Influenza) Vaccine Price (US$/Unit) by Application (2022-2027)
    Table 38. North America Flu (Influenza) Vaccine Sales (K Units) by Company (2016-2021)
    Table 39. North America Flu (Influenza) Vaccine Sales Market Share by Company (2016-2021)
    Table 40. North America Flu (Influenza) Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 41. North America Flu (Influenza) Vaccine Revenue Market Share by Company (2016-2021)
    Table 42. North America Flu (Influenza) Vaccine Sales by Type (2016-2021) & (K Units)
    Table 43. North America Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
    Table 44. North America Flu (Influenza) Vaccine Sales by Type (2022-2027) & (K Units)
    Table 45. North America Flu (Influenza) Vaccine Sales Market Share by Type (2022-2027)
    Table 46. North America Flu (Influenza) Vaccine Sales by Application (2016-2021) & (K Units)
    Table 47. North America Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
    Table 48. North America Flu (Influenza) Vaccine Sales by Application (2022-2027) & (K Units)
    Table 49. North America Flu (Influenza) Vaccine Sales Market Share by Application (2022-2027)
    Table 50. Europe Flu (Influenza) Vaccine Sales (K Units) by Company (2016-2021)
    Table 51. Europe Flu (Influenza) Vaccine Sales Market Share by Company (2016-2021)
    Table 52. Europe Flu (Influenza) Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 53. Europe Flu (Influenza) Vaccine Revenue Market Share by Company (2016-2021)
    Table 54. Europe Flu (Influenza) Vaccine Sales by Type (2016-2021) & (K Units)
    Table 55. Europe Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
    Table 56. Europe Flu (Influenza) Vaccine Sales by Type (2022-2027) & (K Units)
    Table 57. Europe Flu (Influenza) Vaccine Sales Market Share by Type (2022-2027)
    Table 58. Europe Flu (Influenza) Vaccine Sales by Application (2016-2021) & (K Units)
    Table 59. Europe Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
    Table 60. Europe Flu (Influenza) Vaccine Sales by Application (2022-2027) & (K Units)
    Table 61. Europe Flu (Influenza) Vaccine Sales Market Share by Application (2022-2027)
    Table 62. China Flu (Influenza) Vaccine Sales (K Units) by Company (2016-2021)
    Table 63. China Flu (Influenza) Vaccine Sales Market Share by Company (2016-2021)
    Table 64. China Flu (Influenza) Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 65. China Flu (Influenza) Vaccine Revenue Market Share by Company (2016-2021)
    Table 66. China Flu (Influenza) Vaccine Sales by Type (2016-2021) & (K Units)
    Table 67. China Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
    Table 68. China Flu (Influenza) Vaccine Sales by Type (2022-2027) & (K Units)
    Table 69. China Flu (Influenza) Vaccine Sales Market Share by Type (2022-2027)
    Table 70. China Flu (Influenza) Vaccine Sales by Application (2016-2021) & (K Units)
    Table 71. China Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
    Table 72. China Flu (Influenza) Vaccine Sales by Application (2022-2027) & (K Units)
    Table 73. China Flu (Influenza) Vaccine Sales Market Share by Application (2022-2027)
    Table 74. Japan Flu (Influenza) Vaccine Sales (K Units) by Company (2016-2021)
    Table 75. Japan Flu (Influenza) Vaccine Sales Market Share by Company (2016-2021)
    Table 76. Japan Flu (Influenza) Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 77. Japan Flu (Influenza) Vaccine Revenue Market Share by Company (2016-2021)
    Table 78. Japan Flu (Influenza) Vaccine Sales by Type (2016-2021) & (K Units)
    Table 79. Japan Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
    Table 80. Japan Flu (Influenza) Vaccine Sales by Type (2022-2027) & (K Units)
    Table 81. Japan Flu (Influenza) Vaccine Sales Market Share by Type (2022-2027)
    Table 82. Japan Flu (Influenza) Vaccine Sales by Application (2016-2021) & (K Units)
    Table 83. Japan Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
    Table 84. Japan Flu (Influenza) Vaccine Sales by Application (2022-2027) & (K Units)
    Table 85. Japan Flu (Influenza) Vaccine Sales Market Share by Application (2022-2027)
    Table 86. Southeast Asia Flu (Influenza) Vaccine Sales (K Units) by Company (2016-2021)
    Table 87. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Company (2016-2021)
    Table 88. Southeast Asia Flu (Influenza) Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 89. Southeast Asia Flu (Influenza) Vaccine Revenue Market Share by Company (2016-2021)
    Table 90. Southeast Asia Flu (Influenza) Vaccine Sales by Type (2016-2021) & (K Units)
    Table 91. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
    Table 92. Southeast Asia Flu (Influenza) Vaccine Sales by Type (2022-2027) & (K Units)
    Table 93. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Type (2022-2027)
    Table 94. Southeast Asia Flu (Influenza) Vaccine Sales by Application (2016-2021) & (K Units)
    Table 95. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
    Table 96. Southeast Asia Flu (Influenza) Vaccine Sales by Application (2022-2027) & (K Units)
    Table 97. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Application (2022-2027)
    Table 98. India Flu (Influenza) Vaccine Sales (K Units) by Company (2016-2021)
    Table 99. India Flu (Influenza) Vaccine Sales Market Share by Company (2016-2021)
    Table 100. India Flu (Influenza) Vaccine Revenue by Company (2016-2021) & (US$ Million)
    Table 101. India Flu (Influenza) Vaccine Revenue Market Share by Company (2016-2021)
    Table 102. India Flu (Influenza) Vaccine Sales by Type (2016-2021) & (K Units)
    Table 103. India Flu (Influenza) Vaccine Sales Market Share by Type (2016-2021)
    Table 104. India Flu (Influenza) Vaccine Sales by Type (2022-2027) & (K Units)
    Table 105. India Flu (Influenza) Vaccine Sales Market Share by Type (2022-2027)
    Table 106. India Flu (Influenza) Vaccine Sales by Application (2016-2021) & (K Units)
    Table 107. India Flu (Influenza) Vaccine Sales Market Share by Application (2016-2021)
    Table 108. India Flu (Influenza) Vaccine Sales by Application (2022-2027) & (K Units)
    Table 109. India Flu (Influenza) Vaccine Sales Market Share by Application (2022-2027)
    Table 110. Hualan Bio Corporation Information
    Table 111. Hualan Bio Description and Business Overview
    Table 112. Hualan Bio Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 113. Hualan Bio Flu (Influenza) Vaccine Product
    Table 114. Hualan Bio Recent Development
    Table 115. CCBIO Corporation Information
    Table 116. CCBIO Description and Business Overview
    Table 117. CCBIO Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 118. CCBIO Flu (Influenza) Vaccine Product
    Table 119. CCBIO Recent Development
    Table 120. Aleph Biomedical Corporation Information
    Table 121. Aleph Biomedical Description and Business Overview
    Table 122. Aleph Biomedical Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 123. Aleph Biomedical Flu (Influenza) Vaccine Product
    Table 124. Aleph Biomedical Recent Development
    Table 125. SANOFI Corporation Information
    Table 126. SANOFI Description and Business Overview
    Table 127. SANOFI Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 128. SANOFI Flu (Influenza) Vaccine Product
    Table 129. SANOFI Recent Development
    Table 130. Adimmune Corporation Information
    Table 131. Adimmune Description and Business Overview
    Table 132. Adimmune Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 133. Adimmune Flu (Influenza) Vaccine Product
    Table 134. Adimmune Recent Development
    Table 135. ZYAK Corporation Information
    Table 136. ZYAK Description and Business Overview
    Table 137. ZYAK Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 138. ZYAK Flu (Influenza) Vaccine Product
    Table 139. ZYAK Recent Development
    Table 140. SINOVAC Corporation Information
    Table 141. SINOVAC Description and Business Overview
    Table 142. SINOVAC Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 143. SINOVAC Flu (Influenza) Vaccine Product
    Table 144. SINOVAC Recent Development
    Table 145. Changsheng Biological Corporation Information
    Table 146. Changsheng Biological Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 147. Changsheng Biological Description and Business Overview
    Table 148. Changsheng Biological Flu (Influenza) Vaccine Product
    Table 149. Changsheng Biological Recent Development
    Table 150. SIOBP Corporation Information
    Table 151. SIOBP Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 152. SIOBP Description and Business Overview
    Table 153. SIOBP Flu (Influenza) Vaccine Product
    Table 154. SIOBP Recent Development
    Table 155. GSK Corporation Information
    Table 156. GSK Description and Business Overview
    Table 157. GSK Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 158. GSK Flu (Influenza) Vaccine Product
    Table 159. GSK Recent Development
    Table 160. Aimei Hissen Corporation Information
    Table 161. Aimei Hissen Description and Business Overview
    Table 162. Aimei Hissen Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 163. Aimei Hissen Flu (Influenza) Vaccine Product
    Table 164. Aimei Hissen Recent Development
    Table 165. Tianyuan Bio-pharma(Novartis) Corporation Information
    Table 166. Tianyuan Bio-pharma(Novartis) Description and Business Overview
    Table 167. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 168. Tianyuan Bio-pharma(Novartis) Flu (Influenza) Vaccine Product
    Table 169. Tianyuan Bio-pharma(Novartis) Recent Development
    Table 170. Simcere Vaxtec Corporation Information
    Table 171. Simcere Vaxtec Description and Business Overview
    Table 172. Simcere Vaxtec Flu (Influenza) Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2016-2021)
    Table 173. Simcere Vaxtec Flu (Influenza) Vaccine Product
    Table 174. Simcere Vaxtec Recent Development
    Table 175. Production Base and Market Concentration Rate of Raw Material
    Table 176. Key Suppliers of Raw Materials
    Table 177. Flu (Influenza) Vaccine Distributors List
    Table 178. Flu (Influenza) Vaccine Customers List
    Table 179. Flu (Influenza) Vaccine Market Trends
    Table 180. Flu (Influenza) Vaccine Market Drivers
    Table 181. Flu (Influenza) Vaccine Market Challenges
    Table 182. Flu (Influenza) Vaccine Market Restraints
    Table 183. Research Programs/Design for This Report
    Table 184. Key Data Information from Secondary Sources
    Table 185. Key Data Information from Primary Sources
List of Figures
    Figure 1. Flu (Influenza) Vaccine Product Picture
    Figure 2. Global Flu (Influenza) Vaccine Sales Market Share by Type in 2021 & 2027
    Figure 3. Type I Product Picture
    Figure 4. Type II Product Picture
    Figure 5. Global Flu (Influenza) Vaccine Sales Market Share by Application in 2021 & 2027
    Figure 6. For Children (6 months to 3 years) Examples
    Figure 7. For Adults and Children over 3 years Examples
    Figure 8. Global Flu (Influenza) Vaccine Sales, (US$ Million), 2016 VS 2021 VS 2027
    Figure 9. Global Flu (Influenza) Vaccine Sales Growth Rate (2016-2027) & (US$ Million)
    Figure 10. Global Flu (Influenza) Vaccine Sales (K Units) Growth Rate (2016-2027)
    Figure 11. Global Flu (Influenza) Vaccine Price Trends Growth Rate (2016-2027) (US$/Unit)
    Figure 12. Global Flu (Influenza) Vaccine Revenue Market Share by Region: 2016 VS 2021
    Figure 13. Global Flu (Influenza) Vaccine Revenue Market Share by Region: 2021 VS 2027
    Figure 14. North America Flu (Influenza) Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 15. North America Flu (Influenza) Vaccine Sales (K Units) Growth Rate (2016-2027)
    Figure 16. Europe Flu (Influenza) Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 17. Europe Flu (Influenza) Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 18. China Flu (Influenza) Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 19. China Flu (Influenza) Vaccine Sales (Million USD) and Growth Rate (2016-2027)
    Figure 20. Japan Flu (Influenza) Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 21. Japan Flu (Influenza) Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 22. Southeast Asia Flu (Influenza) Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 23. Southeast Asia Flu (Influenza) Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 24. India Flu (Influenza) Vaccine Revenue (Million USD) Growth Rate (2016-2027)
    Figure 25. India Flu (Influenza) Vaccine Sales (Million USD) Growth Rate (2016-2027)
    Figure 26. Global 5 Largest Flu (Influenza) Vaccine Players Market Share by Revenue in Flu (Influenza) Vaccine: 2016 & 2020
    Figure 27. Flu (Influenza) Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
    Figure 28. Global Flu (Influenza) Vaccine Revenue Share by Type (2016-2021)
    Figure 29. Global Flu (Influenza) Vaccine Revenue Growth Rate by Type in 2016 & 2020
    Figure 30. Global Flu (Influenza) Vaccine Revenue Share by Application (2016-2021)
    Figure 31. Global Flu (Influenza) Vaccine Revenue Growth Rate by Application in 2016 & 2020
    Figure 32. North America Flu (Influenza) Vaccine Sales Market Share by Type in 2020
    Figure 33. North America Flu (Influenza) Vaccine Sales Market Share by Application in 2020
    Figure 34. Europe Flu (Influenza) Vaccine Sales Market Share by Type in 2020
    Figure 35. Europe Flu (Influenza) Vaccine Sales Market Share by Application in 2020
    Figure 36. China Flu (Influenza) Vaccine Sales Market Share by Type in 2020
    Figure 37. China Flu (Influenza) Vaccine Sales Market Share by Application in 2020
    Figure 38. Japan Flu (Influenza) Vaccine Sales Market Share by Type in 2020
    Figure 39. Japan Flu (Influenza) Vaccine Sales Market Share by Application in 2020
    Figure 40. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Type in 2020
    Figure 41. Southeast Asia Flu (Influenza) Vaccine Sales Market Share by Application in 2020
    Figure 42. India Flu (Influenza) Vaccine Sales Market Share by Type in 2020
    Figure 43. India Flu (Influenza) Vaccine Sales Market Share by Application in 2020
    Figure 44. Key Raw Materials Price Trend
    Figure 45. Manufacturing Cost Structure of Flu (Influenza) Vaccine 
    Figure 46. Manufacturing Process Analysis of Flu (Influenza) Vaccine
    Figure 47. Flu (Influenza) Vaccine Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation 
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Hualan Bio
CCBIO
Aleph Biomedical
SANOFI
Adimmune
ZYAK
SINOVAC
Changsheng Biological
SIOBP
GSK
Aimei Hissen
Tianyuan Bio-pharma(Novartis)
Simcere Vaxtec
Frequently Asked Questions
Flu (Influenza) Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Flu (Influenza) Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Flu (Influenza) Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Smart Trainers

The global Smart Trainers market is segmented by company, region (country), by Type, and by Appli ... Read More